Sun Pharmaceutical Industries has elevated Aalok Shanghvi, son of the drugmaker’s founder promoter Dilip Shanghvi, as the Chief Operating Officer. Aalok (40 years), continues as Whole-time ...

Dividend stocks today: Shares of six companies, namely Sun Pharmaceutical Industries, Container Corporation of India, IRB Infrastructure Developers, Triveni Turbine, Sharda Cropchem and India ...

Sun Pharma Q3 Results: Sun Pharmaceutical Industries on Friday said its consolidated net profit increased 15 per cent on-year to Rs 2,903 crore in the December quarter, riding on robust sales across ...

The launch timeline of Sun Pharma's specialty drug Leqselvi (deuruxolitinib) continues to be stuck in a limbo even after two quarters since it got embroiled in a patent dispute. The drug ...

Sun Pharma delivered a strong Q3 performance, surpassing Street expectations. However, concerns over the uncertain launch timeline of its hair loss drug Leqselvi and a cut in R&D spending have led ...

Shares of Sun Pharmaceutical Industries Ltd. 524715 inched up 0.40% to 1,749.50 Indian rupees Friday, on what proved to be an all-around dismal trading session for the stock market, with the BSE ...

HYDERABAD/BENGALURU Jan 31 (Reuters) - Sun Pharmaceutical (SUN.NS), opens new tab, India's largest drugmaker by revenue, reported a bigger-than-expected quarterly profit on Friday, aided by strong ...

Sun Pharmaceutical Industries Ltd. 524715 shares inched down 0.77% to 1,753.40 Indian rupees Wednesday, on what proved to be an all-around poor trading session for the stock market, with the BSE ...

Indian stock markets are open today, Saturday, February 1, due to Budget Day. In the previous session on Friday, benchmark indices extended their winning streak to four consecutive sessions ...

AstraZeneca Pharma and GSK Pharma shall be the beneficiaries of the budget announcements. Stocks including ONGC, Sun Pharma, IndusInd Bank, Nestle, Tata Power, Waaree Energies, IRB Infra ...

BENGALURU (Reuters) -India's drug regulator has found more than 50 drugs, including some batches of widely used antacids and paracetamol, to be substandard or fake, according to government documents.

Sun Pharmaceuticals Industries ... Gross NPAs remained unchanged, while net NPAs dropped to 1.28 per cent. Aurobindo Pharma: The pharma company's subsidiary, CuraTeQ Biologics, has received ...